Clinical Trials Directory

Trials / Sponsors / Asahi Kasei Therapeutics Corporation

Asahi Kasei Therapeutics Corporation

Industry · 16 registered clinical trials.

StatusTrialPhaseStarted
CompletedValue of Glycated Albumin in Intervention of Glycemic Control in Chinese Patients With Type 2 Diabetes
Type 2 Diabetes Mellitus
N/A2022-08-15
TerminatedFirst-In-Human Study of AK1320 Encapsulated Microspheres (AK1320 MS)
Degenerative Spondylolisthesis, Spinal Stenosis
Phase 12020-11-18
CompletedClinical Study of AK1820 (Isavuconazonium Sulfate) for the Treatment of Deep Mycosis
Deep Mycosis
Phase 32018-04-16
CompletedExploratory Study of ART-123 for the Prevention of Cancer Treatment Related Symptoms in Patients With Postoper
Postoperative Stage II/III Colon Cancer
Phase 22016-07-01
CompletedClinical Study of ART-123 for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis
Phase 32016-05-01
CompletedLucica ® Glycated Albumin-L Clinical Program - Pivotal Study
Diabetes
—2015-06-01
CompletedA Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Refractory Nephrotic Syndrome
Nephrotic Syndrome
Phase 32014-11-01
CompletedA Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Lupus Nephritis
Lupus Nephritis
Phase 32014-11-01
CompletedA Phase I Study of AK159 in Healthy Postmenopausal Women
Osteoporosis
Phase 12013-08-01
CompletedClinical Pharmacokinetics Study of ART-123 in Disseminated Intravascular Coagulation (DIC) Subjects With Renal
Disseminated Intravascular Coagulation
Phase 42012-10-01
CompletedStudy of HC-58 in Upper Limb Hemiplegic Patients After Stroke
Severe Upper Limb Hemiplegia
Phase 22012-07-01
CompletedCollagenase Option for Reduction of Dupuytren's Contracture in Japan
Dupuytren's Contracture
Phase 32012-05-01
CompletedClinical Study of AK159 in Healthy Postmenopausal Women
Osteoporosis
Phase 12012-03-01
CompletedStudy of AK156 in Primary Osteoporosis Patients
Osteoporosis
Phase 32012-02-01
CompletedA Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA)
Rheumatoid Arthritis
Phase 22011-02-01
CompletedA Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA)
Rheumatoid Arthritis
Phase 22009-05-01